Class action argues Pfizer did not warn about suicide risks

A class action lawsuit has been filed in Canada by three women from British Columbia who say that Pfizer did not give enough warning about the risks of suicidal conduct caused by the smoking cessation drug Champix, which is sold as Chantix in the United States. Go here for the full story.